Funding boost for Vic medtech manufacturer
Breakthrough Victoria has announced a $5bn investment in Neo-Bionica, a Victorian contract medtech manufacturer empowering the next generation of medtech innovators with end-to-end manufacturing and commercialisation services.
Specialising in engineering, bioelectronics and neurotechnology, the Melbourne-based company works with both domestic and international innovators to design and develop implantable and wearable medical devices.
Breakthrough Victoria CEO Grant Dooley said, “Neo-Bionica is unique in Australia — it significantly speeds up the time it takes to develop and trial a medical device, which means people will benefit from the technology earlier.”
“By supporting startups to develop, trial and manufacture medical technology in Victoria, we can ensure these life-saving technologies benefit and prioritise local patients [and] increase jobs and investments in the state.”
Neo-Bionica's facility consists of two workshops and two independent cleanrooms with ISO 7 standard classification, a highly recognised international standard for microfabrication, assembly and testing capabilities.
The company was established in 2021 as a joint initiative of the Bionics Institute and the University of Melbourne and is co-located at St Vincent’s Hospital Melbourne in order to maximise engagement with clinicians.
By offering end-to-end medical device prototype development, clinical trials and initial low-volume manufacturing support, the company plays a vital role in supporting Victorian neurotechnology device innovators and giving them a competitive advantage.
Breakthrough Victoria’s investment will support expansion of Neo-Bionica’s manufacturing capability, facilities and market presence, fuelling commercial growth which will generate up to 45 new jobs.
New framework for clinical quality registries released
The ACSQHC has released a revised framework to support and encourage the use of data to inform...
HL7 Australia appoints David Rowlands as new chair
David Rowlands replaces Dr Isobel Frean, who will be continuing on the board as a non-executive...
Five Faces, Privy announce cross-border collaboration
Australian patient experience software provider Five Faces and Indonesian digital trust provider...